PHYTOCANNABINOIDS (2000-2009)

PHYTOCANNABINOIDS & RELATED COMPOUNDS 2010–2015

PHYTOCANNABINOIDS News Articles 2010-2016

PHYTOCANNABINOIDS & RELATED COMPOUNDS 2000–2009


AMYRINS (Phytochemicals that Inhibit the Breakdown of 2-AG)
ANTHOCYANINS / ANTHOCYADINS (Plant Pigments, Moderately Activate CB1 and CB2 Receptors)
BETA-CARYOPHYLLENE / (E)-BCP (CB2 Agonist, See Also TRANS-CARYOPHYLLENE)
CANNABINOIDS IN OTHER PLANTS (See Also MAGNOLOL, CHOCOLATE, ECHINACEA, TEA (Camellia sinensis L))
CANNADOR (Cannabis Extract in Pill Form)
CANNFLAVIN-A / CANNFLAVIN-B (Non-Cannabinoid Compounds from Cannabis)
CBC / CANNABICHROMENE (Phytocannabinoid, Unknown Receptor)
CBD / CANNABIDIOL / GWP-42003 (Agonist of the 5-HT1A Receptor, Antagonist of CB1 and CB2, GPR–55 and GPR-18)
CBDA / CANNABIDIOLIC ACID (Precursor to Cannabidiol)
CBDV / CANNABIDIVARIN (Unknown Receptor)
CBN / CANNABINOL (CB2 Agonist, Weak CB1 Agonist)
CHOCOLATE (Contains a Tiny Amount of Anandamide and Compounds that Block its Breakdown)
ECHINACEA
ENTOURAGE EFFECT–PHYTOCANNABINOIDS
FLAVONOIDS
GW-42004 (See CBD / CANNABIDIOL)
GWP-42006 (See THCV / TETRAHYDROCANNABIVARIN)
HONKIOL (From Magnolia Trees, CB1 Agonist, CB2 Antagonist, See Also 4’-O-METHYLHONOKIOL, MAGNOLOL)
MAGNOLOL (From Magnolia Trees, CB2 Agonist and GPR-55 Antagonist)
4’-O-METHYLHONOKIOL (From Magnolia Trees, CB2 Agonist, Increases 2-AG Levels. See Also MAGNOLOL, HONKIOL)
PHYTOCANNABINOIDS / PLANT EXTRACTS
SATIVEX / NABIXIMOLS (THC / CBD Cannabis Extract Oral Spray, Legal in UK, NZ, Australia but not USA)
TEA (Camellia sinensis L) (Weakly Activates CB1 and CB2 Receptors)
TERPENOIDS / TERPENES (Help Cannabinoids Work Better, See Also BETA-CARYOPHYLLENE)
THC / TETRAHYDROCANNABINOL (CB1 and CB2 Agonist)
THC ACID / THCA (Non-Psychoactive Precursor of THC)
THC-HS / TETRAHYDROCANNABINOL-HEMISUCCINATE
TETRAHYDROCANNABIORCOL (Activates the TRPA1 Channel like Acetaminophen Does)
THCV / TETRAHYDROCANNABIVARIN / GWP-42004 (CB1 and CB2 Antagonist)
top


AMYRINS
Mechanisms underlying the inhibitory actions of the pentacyclic triterpene α-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate (abst–2006) http://www.sciencedirect.com/science/article/pii/S0014299906014014


ANTHOCYANINS / ANTHOCYADINS
Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15680311
An examination of anthocyanins’ and anthocyanidins’ affinity for cannabinoid receptors (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/20041802


BETA-CARYOPHYLLENE / (E)-BCP
Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene,
isocaryophyllene and paclitaxel (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/18053325
Beta-caryophyllene is a dietary cannabinoid (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2449371/?tool=pmcentrez
Anti-inflammatory cannabinoids in diet (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633791/?tool=pmcentrez
Discovery of a novel cannabinoid in food (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1083900
Salutary pizza spice (news–2008) http://www.eurekalert.org/pub_releases/2008-06/uob-sps062508.php
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pmcentrez
An examination of anthocyanins’ and anthocyanidins’ affinity for cannabinoid receptors (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/20041802


CANNABINOIDS IN OTHER PLANTS
CB receptor ligands from plants (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289087
Immunomodulatory Lipids in Plants: Plant Fatty Acid Amides and the Human Endocannabinoid System (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2008-1034302
top


CANNADOR
Cannabis trial on Parkinson’s (news-2003) http://news.bbc.co.uk/2/hi/uk_news/england/devon/2956273.stm
Can Cannabinoids Counter Parkinson’s Drug Side-effects? (news–2003) http://www.alphagalileo.org/ViewItem.aspx?ItemId=43064&CultureCode=en
A multicenter dose-escalation study of the analgesic and adverse effects of an oral
cannabis extract (Cannador) for postoperative pain management (full-2006) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1922969&resultClick=3
Analgesic and adverse effects of an oral cannabis extract (Cannador) for post-operative pain (abst-2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=184
Cannabis effective at relieving pain after major surgery (news-2006) http://www.news-medical.net/news/2006/05/17/17995.aspx
Cannabis ‘reduces surgery pain’ (news–2006) http://news.bbc.co.uk/2/hi/health/5040960.stm
Cannador: Drug from cannabis plant-extract to reduce surgery pain (news-forum repost-2006) http://www.420magazine.com/forums/cannador/150843-cannador-drug-cannabis-plant-extract-reducesurgery-pain.html
Cannabinoids for postoperative pain. (letter-2007) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1931347&resultClick=3
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755639/
Clinical phase III study with the cannabis extract Cannador successful in multiple sclerosis (news-2009) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=300


CANNFLAVIN-A / CANNFLAVIN-B
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/20223485
Non-cannabinoid constituents from a high potency Cannabis sativa variety (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18774146
Cytotoxic and NF-κB-modulating effects of cannabis constituents (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1084227
top


CBC / CANNABICHROMENE
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
Identification and Determination of Cannabinoids in both Commercially Available and  Cannabis Oils Stored Long Term (full–2005) http://www.researchgate.net/publication/246498903_Identification_and_Determination_of_Cannabinoids_in_both_Commercially_Available_and_Cannabis_Oils_Stored_Long_Term
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study (full-2008) http://www.scribd.com/doc/7718968/Antibacterial-Cannabinoids-From-Cannabis-Sativa-AStructureActivity-Study
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 (full-2008) http://jpet.aspetjournals.org/content/325/3/1007.long
Evaluation of Prevalent Phytocannabinoids in the Acetic Acid Model of Visceral Nociception (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765124/?tool=pubmed
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action (full–2009) http://www.landesbioscience.com/journals/autophagy/SalazarAUTO5-7.pdf


CBD / CANNABIDIOL / GWP – 42004
What Medical Marijuana strain is best for your condition, Sativa or Indica? (news–undated)  http://patientsmarijuana.org/Sativa_or_Indica.html
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
ACCESSING 0.5 to 2.0 GRAMS CBD FRACTIONATING THE PHYTOCANNABINOIDS BY THEIR VAPORIZATION POINTS (article–forum repost-undated) http://forum.grasscity.com/medical-marijuana/610429-need-cbd.html
Cannabinoids might reduce spasticity in multiple sclerosis (full-2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1117698/?tool=pmcentrez
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis (full-2000) http://www.pnas.org/cgi/content/full/97/17/9561
Advantages of polypharmaceutical herbal cannabis compared to single ingredient, synthetic tetrahydrocannabinol (full-2000) http://cannabismovement.org/docs/cannabis%20terpenes.pdf
Variations of D9-THC content in single plants of hemp varieties (full-2000) http://www.ukcia.org/research/VariationOfTHCContent.pdf
top
Neuroprotective Antioxidants from Marijuana (abst–2000) http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2000.tb06193.x/abstract;jsessionid=2FC02E954345A713B5843BEE89616F4F.d02t01
Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid
derivates (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10810367
Different effects of nabilone and cannabidiol on binocular depth inversion in Man (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10837858
Synthesis of a primary metabolite of cannabidiol (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/11029195
Cannabinoids in clinical practice (abst-2000) http://www.ncbi.nlm.nih.gov/pubmed/11152013
Marijuana Extract Helps Arthritis Pain (news-2000) http://www.prohealth.com//library/showArticle.cfm?libid=552
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma
and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572744/
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters
(abst-2001) http://www.ncbi.nlm.nih.gov/pubmed/11566149
Review Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects (full–2002) http://www.doseofnature.com/wp-content/uploads/2014/10/CBD-Chemical-Aspects.pdf
Cannabis and the brain (full-2003) http://brain.oxfordjournals.org/cgi/content/full/126/6/1252
Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-dAspartate-Induced Retinal Neurotoxicity – Involvement of Peroxynitrite (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892413/?tool=pmcentrez
Therapeutic potential of cannabis (full–2003) http://www.ufcw770.org/sites/all/themes/danland/files/TherapeuticPotentialOfCannabis.pdf
Composition of the essential oils and extracts of two populations of Cannabis sativa L ssp. spontanea from Austria (full-forum repost-2003) http://www.420magazine.com/forums/chemical-composition/150878-composition-essential-oils-extractstwo-populations-cannabis-sativa.html
Anti-nausea And Anti-vomiting Activity Of Cannabidiol Compounds/ US 2003 0225156
A1 Dec. 4, 2003 (full–2003) http://www.cannabisinternational.org/info/CBD-Nausea.pdf
Pharmacokinetics and pharmacodynamics of cannabinoids (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12648025
Post-ischemic Treatment with Cannabidiol Prevents Electroencephalographic Flattening, Hyperlocomotion and Neuronal Injury in Gerbils (abst–2003) http://www.sciencedirect.com/science/article/pii/S030439400300569X
Therapeutic potential of cannabinoids in CNS disease (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/12617697
Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic
cannabinoid, in cultured HL-60 myeloblastic leukemia cells (abst-2003) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=14692532&dopt=abstractplus
Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/14644587
top
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies (full-2004) http://www.ukcia.org/research/InitialExperiencesChronicPain.pdf
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells (full-2004) http://www3.interscience.wiley.com/cgi-bin/fulltext/118757302/HTMLSTART
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines (full-2004) http://jpet.aspetjournals.org/content/308/3/838.long
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15640760
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early morning behavior in young adults (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15118485?dopt=Abstract
Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes (abst–forum repost-2004) http://www.420magazine.com/forums/cannabidiol-cbd/150072-cannabidiol-preserves-retinal-neuronsreduces-vascular-permeability-experiment.html
Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain (news–2004) http://www.eurekalert.org/pub_releases/2004-10/sfn-mcm102604.php
Epilepsy and marijuana – a review (full–2005) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492005000200005&lng=en&nrm=iso
Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol Induced Neurotoxicity (full-2005) http://jpet.aspetjournals.org/content/314/2/780.full
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor independent mechanism (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089/?tool=pmcentrez
Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine1A
Receptor–Dependent Mechanism (full-2005) http://stroke.ahajournals.org/cgi/content/full/36/5/1071
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (full-2005)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270485/?tool=pmcentrez
Cannabidiol as an antipsychotic. A double-blind, controlled clinical trial on cannabidiol vs. amisulpride in acute schizophrenia (full-2005) http://www.nature.com/tp/journal/v2/n3/full/tp201215a.html
Identification and Determination of Cannabinoids in both Commercially Available and Cannabis Oils Stored Long Term (full–2005) http://www.researchgate.net/publication/246498903_Identification_and_Determination_of_Cannabinoids_in_both_Commercially_Available_and_Cannabis_Oils_Stored_Long_Term
top
Peripheral, but not central effects of cannabidiol derivatives: Mediation by CB 1 and unidentified receptors (full-2005) http://www.researchgate.net/publication/7830541_Peripheral_but_not_central_effects_of_cannabidiol_derivatives_mediation_by_CB%281%29_and_unidentified_receptors
Pharmaceutical Formulation. US Patent 6946150 B27 (full–2005)
http://www.cannabisinternational.org/info/nasal-spray.pdf
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival (abst-2005) http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16183560
Pharmacokinetics of cannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16237477
Treatment with CBD in oily solution of drug-resistant paediatric epilepsies (abst-2005) http://www.cannabismed.org/studies/ww_en_db_study_show.php?s_id=173&&search_pattern=EPILEPSY
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15837565?dopt=Abstract
Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol (abst–2005)
http://www.ncbi.nlm.nih.gov/pubmed/16596792
Chemicals in Cannabis may help mentally ill (news-2005)
http://www.news-medical.net/news/2005/06/06/10716.aspx
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full-2006)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592672/?tool=pubmed
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the
Management of Acute and Chronic Pain Episodes (full-2006)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430692/?tool=pubmed
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (full-2006) http://mcforadhd.free.fr/Russo_Tale_of_Two_Cannabinoids_Med_Hypoth_2006.pdf
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug (full-2006) http://www.scielo.br/scielo.php?pid=S0100-879X2006000400001&script=sci_arttext#Text
Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression (full-2006) http://molpharm.aspetjournals.org/content/70/3/897.long
top
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma (full-2006) http://jpet.aspetjournals.org/content/318/3/1375.full
Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats (full-2006) http://www.sciencedirect.com/science/article/pii/S0014579306008155
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug
resistant cells (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16458258
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16876926
Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal
neurones and glia (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16997463?dopt=Abstract
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in
human glioma cells (abst-2006) http://www.ihop-net.org/UniPub/iHOP/pm/12214911.html?pmid=16909207
The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein
hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16389547
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NFkappaB involvement (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16490313
Cannabidiol inhibits tumour growth in leukaemia and breast cancer (news-2006)
http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=220#2
Compound found in marijuana may defend against diabetic retinopathy (news–2006) http://www.news-medical.net/news/2006/03/01/16284.aspx
Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says (news-2006) http://norml.org/news/2006/05/18/non-psychoactive-cannabinoid-reduces-incidence-of-diabetes-study-says
Cannabidiol reduces the development of diabetes in an animal study (news-2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=219#3
Getting Eye On Cannabinoids (news-2006) http://www.thehempire.com/index.php/cannabis/news/getting_eye_on_cannabinoids
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells (full-2007) http://mct.aacrjournals.org/content/6/11/2921.long
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full-2007)
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2219532&tool=pmcentrez
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption (full-2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2228254&tool=pmcentrez
top
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β
and iNOS expression (full-2007) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189818&tool=pmcentrez
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury (full-2007) http://ajpheart.physiology.org/cgi/content/full/293/6/H3602
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189767/?tool=pubmed
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid
receptor-independent myeloperoxidase-inhibiting mechanism (full-2007) http://www3.interscience.wiley.com/cgi-bin/fulltext/118484119/HTMLSTART
Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity (full-2007) http://www.jneurosci.org/cgi/content/full/27/36/9537
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells (full–2007) http://www.jleukbio.org/content/early/2007/03/05/jlb.1206738.full.pdf+html
The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190019/?tool=pubmed
US Patent 8071641 B2 – Treating or preventing diabetes with cannabidiol (full–2007) http://www.google.com/patents/US8071641
Repeated Treatment with Cannabidiol but Not Delta9-tetrahydrocannabinol Has a Neuroprotective Effect Without the Development of Tolerance (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17320118
Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17419758
Cannabidiol–recent advances (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17712814
Identification of the vasodilatory endothelial cannabinoid receptor in the human
pulmonary artery (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17921818
Who’s Afraid of Cannabidiol? (news-2007) http://www.counterpunch.org/2007/07/14/who-s-afraid-of-cannabidiol/
Cannabidiol May be Effective in Preventing Bovine Spongiforme Enzephalopathy (Mad
Cow Disease) (news-2007) http://www.letfreedomgrow.com/articles/fr070916.htm
Marijuana Compound Shows Promise In Fighting Breast Cancer (news-2007) http://www.sciencedaily.com/releases/2007/11/071123211703.htm
Cannabis compound cannabidiol CBD ‘halts cancer (news-2007) http://news.bbc.co.uk/2/hi/health/7098340.stm
Cannabis compound stops spread of breast cancer: researchers (news-2007) http://www.cbc.ca/news/technology/cannabis-compound-stops-spread-of-breast-cancer-researchers-1.675379
top
Pot Compound Protective Against ‘Mad Cow’ Disease, Other Fatal Brain Disorders, Study Says (news-2007) http://norml.org/news/2007/09/13/pot-compound-protective-against-mad-cow-disease-other-fatal-braindisorders-study-says
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol (full-2008) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2279017
Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor (full-2008)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588644/?tool=pmcentrez
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study (full-2008) http://www.scribd.com/doc/7718968/Antibacterial-Cannabinoids-From-Cannabis-Sativa-AStructureActivity-Study
Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2451037/?tool=pmcentrez
Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592995/?tool=pubmed
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis (full-2008) http://bjp.rcpsych.org/cgi/content/full/192/4/306?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1200&resourcetype=HWCIT
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action (full-2008) http://www.finola.com/CBDreview2008.pdf
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 (full-2008) http://jpet.aspetjournals.org/content/325/3/1007.long
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full–2008) http://molpharm.aspetjournals.org/content/73/2/441.long
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2007.05073.x/full
US Patent 7399872 – Conversion of CBD to Δ-THC and Δ-THC (full-2008) https://www.google.com/patents/US7399872
US Patent Application 20080262099 – Inhibition of Tumour Cell Migration (full–2008) http://www.freepatentsonline.com/y2008/0262099.html
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase (full–2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2008.01114.x/full
The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/19045957
The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18781980
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cell (abst-2008) http://www.greenmedinfo.com/article/cannabinoids-may-have-therapeutic-role-play-treating-thyoma
top
Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders (abst-2008) http://www.unboundmedicine.com/medline/ebm/record/18844286/abstract/Cannabidiol_in_medicine:_a_review_of_its_therapeutic_potential_in_CNS_disorders_
Cytotoxic and NF-κB-modulating effects of cannabis constituents (abst–2008)
https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1084227
Inhibition of Breast Cancer Aggressiveness by Cannabidiol (abst-2008) http://www.cannabisoils.ca/inhibition-of-breast-cancer-aggressiveness-by-cannabidiol
Scheduling process at DEA – the example of cannabidiol (abst–2008) http://www.fasebj.org/cgi/content/meeting_abstract/22/1_MeetingAbstracts/711.1
Weeding out the highs of medical marijuana (news–2008)
http://www.alphagalileo.org/ViewItem.aspx?ItemId=4726&CultureCode=en
Therapeutic time window of cannabidiol treatment on delayed ischemic damage via highmobility group box1-inhibiting mechanism (full–2009) https://www.jstage.jst.go.jp/article/bpb/32/9/32_9_1538/_pdf
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells (full–2009) http://www.jbc.org/content/285/3/1616.full?sid=43211ca4-a4aa-4182-a554-d15e2835e288
Non-psychotropic plant cannabinoids:new therapeutic opportunities from an ancient herb (full-2009) http://www.onlinepot.org/medical/Izzo%20Plant%20Cannabinoids%20Therapeutic%20Opportunities%20TIPS%202009.pdf
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pubmed
Evaluation of Prevalent Phytocannabinoids in the Acetic Acid Model of Visceral Nociception (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765124/?tool=pubmed
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737440/?tool=pubmed
Cannabinoids as novel anti-inflammatory drugs (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed
Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin
Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances (full-2009)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829756/?tool=pmcentrez
Opposite Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Human Brain
Function and Psychopathology (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055598/pdf/npp2009184a.pdf
Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955420/?tool=pubmed
Non-psychotropic plant cannabinoids:new therapeutic opportunities from an ancient herb (full-2009) http://www.onlinepot.org/medical/Izzo%20Plant%20Cannabinoids%20Therapeutic%20Opportunities%20TIPS%202009.pdf
Cannabidiol: a promising drug for neurodegenerative disorders? (full-2009) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2008.00065.x/full
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative / Nitrosative Stress, Inflammation, and Cell Death (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682269/
top
Cannabidiol-induced lymphopenia does not involve NKT and NK cells (full–2009) http://www.jpp.krakow.pl/journal/archive/10_09_s3/pdf/99_10_09_s3_article.pdf
Cannabidiol-2′,6′-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor (full-2009) http://dmd.aspetjournals.org/content/37/8/1733.long
Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels (full–2009) http://www.jneurosci.org/content/29/7/2053.long
Cannabidiol Attenuates Myocardial Dysfunction, Fibrosis, Inflammation, Cell Death and Interrelated Signaling Pathways Associated With Diabetic Cardiomyopathy (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026637/
Modulation of effective connectivity during emotional processing by Delta9-tetrahydrocannabinol and cannabidiol (full-2009) http://ijnp.oxfordjournals.org/content/13/4/421.long
US Patent Application 20090197941 – Pharmaceutical Compositons for the Treatment of Chronic Obstructive Pulmonary Disease (full–2009) http://www.google.com/patents/US20090197941
Pharmaceutical Compositions For The Treatment Of Chronic Obstructive Disease IS2009 / 0197941 A1 Aug. 6, 2009 (full–2009) http://www.cannabisinternational.org/info/COPD-Compositions.pdf
US Patent Application 20090005461 – Use of Cannabidiol in the Treatment of Hepatitis (full–2009) http://www.google.com/patents/US20120302646
Role of the cannabinoids in glaucoma (article–2009) http://www.oftalmo.com/seo/archivos/maquetas/8/3E3FF941-D9FB-6F89-02E1-00007B09B2A8/articulo.pdf
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania (abst–2009) http://jop.sagepub.com/content/25/2/274.abstract
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function (abst–2009)
http://content.karger.com/produktedb/produkte.asp?DOI=000201556&typ=pdf
Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and proinflammatory cytokines during experimental periodontitis in rats (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19070683
Time-dependent vascular actions of cannabidiol in the rat aorta (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19285060
Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19441010/abstract/
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19690824/abstract/Cannabidiol_a_safe_and_non_psychotropic_ingredient_of_the_marijuana_plant_Cannabis_sativa_is_protective_in_a_murine_model_of_colitis_
top
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19596476/abstract/Cannabidiol_ameliorates_cognitive_and_motor_impairments_in_mice_with_bile_duct_ligation_
Cannabidiol for the treatment of psychosis in Parkinson’s disease (abst-2009) http://jop.sagepub.com/cgi/content/abstract/23/8/979?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=1920&resourcetype=HWCIT
Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19393686
Cannabis compound can help cells (news–2009) http://www.physorg.com/news154280470.html
Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug (news–2009) http://www.thefreelibrary.com/Cannabis+plant+extracts+could+potentially+form+the+basic+ingredients…-a0202701009
Marijuana Chemicals Ease MS Symptoms, Review Confirms (news-2009) http://www.drugfree.org/uncategorized/marijuana-chemicals-ease-ms
Cannabis by product helps reduce effects of Parkinson disease medication (news-2009) http://en.mercopress.com/2009/12/30/cannabis-by-product-helps-reduce-effects-ofparkinson-disease-medication/


CBDA / CANNABIDIOLIC ACID
Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10810367
Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type
Cannabis sativa (full–2007) http://www.sciencedirect.com/science/article/pii/S0014579307005728
Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis (full–2008) http://dmd.aspetjournals.org/content/36/9/1917.long
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 (full-2008) http://jpet.aspetjournals.org/content/325/3/1007.long


CBDV / CANNABIDIVARIN
A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae) (full-2004) http://www.amjbot.org/cgi/content/full/91/6/966
Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15688956
top


CBN / CANNABINOL
Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10810367
Identification and Determination of Cannabinoids in both Commercially Available and Cannabis Oils Stored Long Term (full–2005) http://www.researchgate.net/publication/246498903_Identification_and_Determination_of_Cannabinoids_in_both_Commercially_Available_and_Cannabis_Oils_Stored_Long_Term
Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16596792
Pharmacokinetics of cannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16237477
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16458258
Cytotoxic and NF-κB-modulating effects of cannabis constituents (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1084227


CHOCOLATE
Cannabinoid mimics in chocolate utilized as an argument in court (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10876983
Chocolate and cannabis (article–2005) http://www.cannabisculture.com/content/2005/05/09/4337
Anandamide in Chocolate (news–2005) http://www.herbmuseum.ca/content/anandamide-chocolate
Delirium following ingestion of marijuana present in chocolate cookies (full-2006) http://www.cnsspectrums.com/aspx/articledetail.aspx?articleid=357
Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16491428
Health Benefits of Chocolate (news–2007) http://chocolate.org/health/chocprescribe.html
top


ECHINACEA
Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways (full–2004) http://www.sciencedirect.com/science/article/pii/S0014579304013183
The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16142631
Alkylamides from Echinacea Are a New Class of Cannabinomimetics (full–2006) http://www.jbc.org/content/281/20/14192.full
New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17118807
The Role of Alkamides as an Active Principle of Echinacea (full–2007) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-2007-981531
CB receptor ligands from plants (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18289087
Analgesic and neuropsychological effects of Echinacea N-alkylamides (abst–2008)
https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1084300
Synthesis and cannabinoid receptor activity of ketoalkenes from Echinacea pallida and nonnatural analogues (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18979494
Immunomodulatory Lipids in Plants: Plant Fatty Acid Amides and the Human Endocannabinoid System (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2008-1034302
Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19712756
Synergistic immunopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts (abst–2009) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1234654


ENTOURAGE EFFECT–PHYTOCANNABINOIDS
Advantages of polypharmaceutical herbal cannabis compared to single ingredient,
synthetic tetrahydrocannabinol (full-2000) http://cannabismovement.org/docs/cannabis%20terpenes.pdf
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? (full-2001) http://www.cannabis-med.org/membersonly/mo.php?aid=2001-03-04&fid=2001-03-04-7&mode=p&sid=
Cannabinoids – from plant to patient. 5 April 2001, London, UK (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/15995932
Natural cannabis ‘better than extracts’ (news-2001) http://news.bbc.co.uk/2/hi/health/1261737.stm
top
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574194/
Chemical constituents of marijuana: the complex mixture of natural cannabinoids (full–2005) http://www.scribd.com/doc/46441536/Chem-Constitutes-of-Marijuana
A tale of two cannabinoids:The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (full-2006) http://mcforadhd.free.fr/Russo_Tale_of_Two_Cannabinoids_Med_Hypoth_2006.pdf
‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/?tool=pubmed
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18618522


FLAVONOIDS
Cannabinoids – from plant to patient. 5 April 2001, London, UK (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/15995932
Chemotaxonomic features associated with flavonoids of cannabinoid-free cannabis
(Cannabis sativa subsp. sativa L.) in relation to hops (Humulus lupulus L) (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/11942684
NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15595449?ordinalpos=53&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug
resistant cells (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16458258
PKS activities and biosynthesis of cannabinoids and flavonoids in Cannabis sativa L plants (full-2008) http://pcp.oxfordjournals.org/content/49/12/1767.long
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18618522
top


HONKIOL
Magnolia officinalis is a Traditional Chinese Medicine (article–undated) http://examine.com/supplements/Magnolia+officinalis/
MAGNOLIA BARK (article–2001) http://www.itmonline.org/arts/magnolia.htm
Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo (full–2003) http://www.jbc.org/content/278/37/35501.long
Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO (full–2004) http://www.wjgnet.com/1007-9327/full/v10/i15/2205.htm
Honokiol: a potent chemotherapy candidate for human colorectal carcinoma (full–2004) http://www.wjgnet.com/1007-9327/full/v10/i23/3459.htm
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells (full–2005) http://bloodjournal.hematologylibrary.org/content/106/2/690.long
Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis (full–2007) http://www.jimmunol.org/content/179/2/753.long
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18588872
Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2) (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18507762
Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18350317
Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18440692
Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18798493
Effects of storage time on magnolol and honokiol contents in bark of Magnolia officinalis (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19066046
Honokiol, a multifunctional antiangiogenic and antitumor agent (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842137/
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795513/
Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c (full–2009)
https://www.jstage.jst.go.jp/article/jphs/109/4/109_08182FP/_pdf
top


MAGNOLOL
MAGNOLIA BARK (article–2001) http://www.itmonline.org/arts/magnolia.htm
Effects of storage time on magnolol and honokiol contents in bark of Magnolia officinalis (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19066046
Magnolia officinalis reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element-binding protein-1c (full–2009) https://www.jstage.jst.go.jp/article/jphs/109/4/109_08182FP/_pdf
NAMISOL–a THC tablet Holland: Echo Pharmaceuticals develops THC tablet Namisol (news–2008) http://www.cannabismed.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=265&search_pattern=vaporizer


4’-O-METHYLHONOKIOL
Magnolia officinalis is a Traditional Chinese Medicine (article–undated) http://examine.com/supplements/Magnolia+officinalis/
MAGNOLIA BARK (article–2001) http://www.itmonline.org/arts/magnolia.htm
Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690856/


PHYTOCANNABINOIDS / PLANT EXTRACTS
What Medical Marijuana strain is best for your condition, Sativa or Indica? (news–undated)  http://patientsmarijuana.org/Sativa_or_Indica.html
Phytocannabinoids (news–undated)
http://www.news-medical.net/health/Phytocannabinoids.aspx
ACCESSING 0.5 to 2.0 GRAMS CBD FRACTIONATING THE PHYTOCANNABINOIDS BY THEIR VAPORIZATION POINTS (article–forum repost-undated) http://forum.grasscity.com/medical-marijuana/610429-need-cbd.html
Cannabinoids (encyclopedia entry) http://www.chemie.de/lexikon/e/Cannabinoids/
The Science of Marijuana (book–2000) http://www.green215.com/sites/all/files/education_articles/Science%20Cannabis.pdf
Advantages of polypharmaceutical herbal cannabis compared to single ingredient, synthetic tetrahydrocannabinol (full-2000)
http://cannabismovement.org/docs/cannabis%20terpenes.pdf
top
Immunoactive cannabinoids: Therapeutic prospects for marijuana constituents (full-2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC34030/?tool=pubmed
Variations of D9-THC content in single plants of hemp varieties (full-2000)
http://www.ukcia.org/research/VariationOfTHCContent.pdf
Cannabinoids in clinical practice (abst-2000) http://www.ncbi.nlm.nih.gov/pubmed/11152013
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts? (full-2001) http://www.cannabis-med.org/membersonly/mo.php?aid=2001-03-04&fid=2001-03-04-7&mode=p&sid=
Cannabinoids – from plant to patient. 5 April 2001, London, UK (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/15995932
Natural cannabis ‘better than extracts’ (news-2001) http://news.bbc.co.uk/2/hi/health/1261737.stm
Whether whole plant Cannabis extracts can improve intractable neurogenic symptoms? (full-2003) http://www.ukcia.org/research/WholePlantExtractsImproveNeurogenicSymptoms.pdf
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study (full-2004) http://www.ukcia.org/research/EfficacySafetyTolerabilityInMSSpasticityTreatment.pdf
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies (full-2004) http://www.ukcia.org/research/InitialExperiencesChronicPain.pdf
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial (full-2004) http://www.ukcia.org/research/CentralNeuropathicPainEfficacy.pdf
Cannabis can help MS sufferers (news–2004) http://www.safeaccessnow.org/asanews777
Cannabis truly helps multiple sclerosis sufferers (news-2004)
http://www.cannabisnews.com/news/19/thread19477.shtml
Plant cannabinoids: a neglected pharmacological treasure trove (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751232/?tool=pubmed
Chemical constituents of marijuana: the complex mixture of natural cannabinoids (full–2005) http://www.scribd.com/doc/46441536/Chem-Constitutes-of-Marijuana
US Patent Application 20050266108 – Methods of purifying cannabinoids from plant material (full-2005) http://www.google.com/patents/US20050266108
A tale of two cannabinoids:The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (full-2006) http://mcforadhd.free.fr/Russo_Tale_of_Two_Cannabinoids_Med_Hypoth_2006.pdf
top
Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways (full-2006) https://openaccess.leidenuniv.nl/bitstream/handle/1887/3744/07.pdf?sequence=6
The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190019/?tool=pubmed
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189766/?tool=pubmed
Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology (full-2007) http://www.sciencedirect.com/science/article/pii/S1074552107002062
Medicinal chemistry endeavors around the phytocannabinoids (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17712816
Cannabis tinctures and extracts – in vitro profiling for cytotoxic and anti-inflammatory effects (abst–2007) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2007-986840
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study (full-2008) http://www.scribd.com/doc/7718968/Antibacterial-Cannabinoids-From-Cannabis-Sativa-AStructureActivity-Study
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 (full-2008)
http://jpet.aspetjournals.org/content/325/3/1007.long
PKS activities and biosynthesis of cannabinoids and flavonoids in Cannabis sativa L.
plants (full-2008) http://pcp.oxfordjournals.org/content/49/12/1767.long
Patent 7344736 – Extraction of pharmaceutically active components from plant materials (full–2008) http://www.freepatentsonline.com/7344736.html
Pain relief with cannabinoids – the importance of endocannabinoids and cannabinoids for pain therapy (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18671173
Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18618522
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1) (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18619955
Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18275004
Non-psychotropic plant cannabinoids:new therapeutic opportunities from an ancient herb (full-2009) http://www.onlinepot.org/medical/Izzo%20Plant%20Cannabinoids%20Therapeutic%20Opportunities%20TIPS%202009.pdf
top
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697695/?tool=pubmed
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765124/?tool=pubmed
Phytocannabinoids and endocannabinoids (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19630737
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/18777572
Fungal biotransformation of cannabinoids: potential for new effective drugs (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19333876
Phytocannabinoid scientists unveils lozenge to treat H1N1 swine flu and H5N1 bird flu (news/ad-2009) http://www.lycaeum.org/forum/index.php?topic=27233.0


SATIVEX / NABIXIMOLS
medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis (full-2005) http://rheumatology.oxfordjournals.org/cgi/content/full/45/1/50
Sativex Drug Momograph (monograph–2005) http://www.ukcia.org/research/SativexMonograph.pdf
Sativex: Fact Sheet (full-2005) http://www.bayer.ca/files/sativex_fs_fd_091289_e.pdf
Sativex: Health Care Professional letter (letter-2005) http://www.bayer.ca/files/sativex_dhcpl_lapds_091289_e.pdf
Sativex produced significant improvements in a subjective measure of spasticity (abst-2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=170
Cannabis-based medicinal extract (Sativex) produced significant improvements in a subjective measure of spasticity which were maintained on long-term treatment with no evidence of tolerance (abst-2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=170
UK: Cannabis drug Sativex available to MS patients (news–2005)
http://www.chanvre-info.ch/info/it/UK-Cannabis-drug-Sativex-available.html
Conditional okay for cannabis prescription drug (news-2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1150250&tool=pmcentrez
Cannabis-Based Drug Relieves Arthritis Pain (news-2005)
http://www.medpagetoday.com/Rheumatology/Arthritis/2097
Cannabis-based medicine relieves the pain of rheumatoid arthritis and suppresses the disease (news–2005) http://www.eurekalert.org/pub_releases/2005-11/oup-cmr110705.php
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis (full-2006) http://rheumatology.oxfordjournals.org/cgi/content/full/45/1/50?maxtoshow=&hitqs=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=2240&resourcetype=HWCIT
top
Cannabinoids In Medicine: A Review Of Their Therapeutic Potential (full–2006) http://www.doctordeluca.com/Library/WOD/WPS3-MedMj/CannabinoidsMedMetaAnalysis06.pdf
The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis (letter-2006) http://rheumatology.oxfordjournals.org/cgi/content/full/45/6/781
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/17086911
Randomised controlled study of cannabis-based medicine (Sativex®) in patients suffering from multiple sclerosis associated detrusor overactivity (abst-2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=168
Sativex® in patients with symptoms of spasticity due to multiple sclerosis (abst-2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=169
Combined cannabinoid therapy via an oromucosal spray (abst–2006) http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=1021517
Sativex showed positive effects in 65 per cent of patients with chronic diseases (news-2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=230#4
Sativex: Fact Sheet (full-2007) http://www.bayer.ca/files/sativex_fs_fd_109461_e%20_GW_.pdf
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013961/pdf/0707261a.pdf
Cannabis; adverse effects from an oromucosal spray (full-2007) http://www.nature.com/bdj/journal/v203/n6/pdf/bdj.2007.749.pdf
Sativex: Health Care Professional letter (letter-2007) http://www.bayer.ca/files/sativex_dhcpl_lapds_109461_e%20_GW_-2.pdf
Letter: Cannabinoid medicines and the need for the scientific method (letter–2007) http://www.cannabis-med.org/data/pdf/en_2007_02_3.pdf
Letter: The herbal way – a response to Ethan Russo (letter–2007) http://www.cannabis-med.org/data/pdf/en_2007_03_1.pdf
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis based medicine (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17712817
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17868014
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17997224
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/18035205
top
Cannabinoids in the management of difficult to treat pain (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/?tool=pmcentrez
SUPPORTING RESEARCH INTO THE THERAPEUTIC ROLE OF MARIJUANA (full–2008) https://www.acponline.org/acp_policy/policies/supporting_medmarijuana_2008.pdf
Weeding out the highs of medical marijuana (news–2008) http://www.alphagalileo.org/ViewItem.aspx?ItemId=4726&CultureCode=en
Emerging strategies for exploiting cannabinoid receptor agonists as medicines (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697681/
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755639/


TEA (Camellia sinensis L)
Synthesis of potential theanine metabolites, related structures and their affinity for CB receptors (abst–2007) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2007-986803
Catechin-derivates affinity for human cannabinoid receptors (abst–2009) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1234837


TERPENOIDS / TERPENES
THC (TETRAHYDROCANNABINOL) ACCUMULATION IN GLANDS OF CANNABIS (CANNABACEAE) (full–undated) http://www.hempreport.com/issues/17/malbody17.html
Cannabinoid Receptor 1 Binding Activity and Quantitative Analysis of Cannabis sativa L. Smoke and Vapor (full–2009) https://www.jstage.jst.go.jp/article/cpb/58/2/58_2_201/_pdf


THC / TETRAHYDROCANNABINOL
What Medical Marijuana strain is best for your condition, Sativa or Indica? (news–undated) http://patientsmarijuana.org/Sativa_or_Indica.html
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
Tetrahydrocannabinol- an interview with Akshat Rathi (interview-undated) http://www.rsc.org/chemistryworld/podcast/CIIEcompounds/transcripts/THC.asp
top
The Science of Marijuana (book–2000) http://www.green215.com/sites/all/files/education_articles/Science%20Cannabis.pdf
Advantages of polypharmaceutical herbal cannabis compared to single ingredient, synthetic tetrahydrocannabinol (full-2000) http://cannabismovement.org/docs/cannabis%20terpenes.pdf
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation
and extracellular signal-regulated kinase activation (full-2000) http://depts.washington.edu/stellalb/images/Nature2000.pdf
Cannabinoids might reduce spasticity in multiple sclerosis (full-2000) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1117698/?tool=pmcentrez
Variations of D9-THC content in single plants of hemp varieties (full-2000) http://www.ukcia.org/research/VariationOfTHCContent.pdf
GC-MS analysis of the total delta9-THC content of both drug- and fiber-type cannabis seeds (full–2000) http://jat.oxfordjournals.org/content/24/8/715.long
Endogenous cannabinoids and appetite (full–2000) http://journals.cambridge.org/download.php?file=%2FNRR%2FNRR14_01%2FS095442240100004Xa.pdf&code=840ac1e121b1a8563a840b894cced959
Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10810367
Cannabinoids in clinical practice (abst-2000) http://www.ncbi.nlm.nih.gov/pubmed/11152013
Effects of smoked cannabis and oral d9-tetrahydrocannabinol on nausea and emesis after cancer chemotherapy (full–2001) http://www.cannabis-med.org/data/pdf/2001-01-2.pdf
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A (full–2001) http://www.nature.com/npp/journal/v24/n2/full/1395605a.html
Neuroprotection by Delta 9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity (full-2001)
http://www.jneurosci.org/content/21/17/6475.full
Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma  and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide (full–2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572744/
Tetrahydrocannabinol for treatment of chronic pain (abst-2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=147
Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive bladders in spinal cord injury (SCI) patients (abst-2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=102
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease (full-2002) http://bloodjournal.hematologylibrary.org/cgi/content/full/100/2/627?ijkey=eb71d6d7a06f311440761cfac6a7d081bcc2771d
top
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid (full–2002) http://www.eje-online.org/content/147/2/255.full.pdf+html
The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids (full–2002) http://jpet.aspetjournals.org/content/300/1/34.long
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis (full-2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1222465/pdf/11903061.pdf
Functional role for cannabinoids in respiratory stability during sleep (link to PDF-2002) http://www.journalsleep.org/ViewAbstract.aspx?pid=25731
Cannabinoids and multiple sclerosis (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12182963
Cannabinoids in the treatment of pain and spasticity in multiple sclerosis (abst-2002) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12137404&dopt=abstractplus
Natural High Erases Bad Memories (news-2002) http://www.cbsnews.com/news/natural-high-erases-bad-memories/
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN (full-2003) http://www.jleukbio.org/cgi/content/full/75/3/453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy (full-2003)
http://jpet.aspetjournals.org/content/307/1/129.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
Inhibition of tumor angiogenesis by cannabinoids (full-2003) http://www.fasebj.org/cgi/reprint/02-0795fjev1?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=20&sortspec=relevance&resourcetype=HWCIT
Effects of THC on Behavioral Measures of Impulsivity in Humans (full-2003) http://www.nature.com/npp/journal/v28/n7/full/1300176a.html
Cannabis and the brain (full-2003) http://brain.oxfordjournals.org/cgi/content/full/126/6/1252
Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Delta9-THC): No Influence on Neuropsychological Performance (full-2003)
http://www.nature.com/npp/journal/v28/n2/abs/1300047a.html
Cannabinoids: Potential Anticancer Agents (full-2003) http://americanmarijuana.org/Guzman-Cancer.pdf
Therapeutic potential of cannabis (full–2003) http://www.ufcw770.org/sites/all/themes/danland/files/TherapeuticPotentialOfCannabis.pdf
top
Cannabis use for chronic non-cancer pain: results of a prospective survey (abst-2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=91
The treatment of spasticity with D9-THC) in patients with spinal cord injury (abst-2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=79
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716 (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12447606
Regulation of Cannabinoid CB1 Receptors in the Central Nervous System by Chronic Cannabinoids (abst–2003) http://dl.begellhouse.com/journals/7b004699754c9fe6,5aa33979065f2aa3,42019b6a7dd932fb.html
Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial (abst-2003) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=146#1
The endocannabinoid system as a target for the development of new drugs for cancer therapy (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12723496
Pharmacokinetics and pharmacodynamics of cannabinoids (abst–2003) http://www.ncbi.nlm.nih.gov/pubmed/12648025
Keeping the Brain’s Activity under Control (news–2003) http://www.mpg.de/481862/pressRelease20031022?filter_order=L
Differential Effects of THC or CBD-rich Cannabis Extracts on Working Memory in Rats (full-2004) http://www.ukcia.org/research/THCCBDWorkingMemory.pdf
Cannabinoids: Defending the Epileptic Brain (full-2004)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1176332/?tool=pmcentrez
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake (full–2004) http://press.endocrine.org/doi/full/10.1210/en.2004-0059
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies (full-2004) http://www.ukcia.org/research/InitialExperiencesChronicPain.pdf
The THC-induced suppression of Th1 polarization in response to Legionella
pneumophila infection is not mediated by increases in corticosterone and PGE2 (full–2004) http://www.jleukbio.org/content/76/4/854.long
The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human Platelets (full-2004) http://journals.lww.com/anesthesiaanalgesia/pages/articleviewer.aspx?year=2004&issue=10000&article=00031&type=Fulltext
Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids (link to PDF–2004) http://www.biochemj.org/content/380/2/435.full-text.pdf
The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15302527
top
Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15099912
Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early morning behavior in young adults (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/15118485?dopt=Abstract
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15640759
A Comparison of the Discriminative Stimulus Effects of Δ⁹-Tetrahydrocannabinol and O-1812, a Potent and Metabolically Stable Anandamide Analog, in Rats (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15301634
[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Delta9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15110734
THC in marijuana may block the spread of forms of cancer causing herpes viruses (news-2004) http://www.news-medical.net/news/2004/09/22/4990.aspx
Cannabis truly helps multiple sclerosis sufferers (news-2004) http://www.cannabisnews.com/news/19/thread19477.shtml
Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain (news–2004) http://www.eurekalert.org/pub_releases/2004-10/sfn-mcm102604.php
Cannabinoids spell relief in colon inflammation (news–2004) http://www.mpg.de/496761/pressRelease20040506?filter_order=L
Cannabis can help MS sufferers (news–2004) http://www.safeaccessnow.org/asanews777
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice (full-2005) http://www.nature.com/nature/journal/v434/n7034/full/nature03389.html
Epilepsy and marijuana – a review (full–2005) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492005000200005&lng=en&nrm=iso
Synergistic Interactions between Cannabinoids and Environmental Stress in the Activation of the Central Amygdala (full-2005) http://www.nature.com/npp/journal/v30/n3/full/1300535a.html
Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1824211/?tool=pmcentrez
Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes (full–2005) http://pcp.oxfordjournals.org/content/46/9/1578.long
Cannabinoids and cancer: potential for colorectal cancer therapy (full-2005) http://www.biochemsoctrans.org/bst/033/0712/bst0330712.htm
The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576168/?tool=pmcentrez
top
p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells (full–2005) http://www.sciencedirect.com/science/article/pii/S0014579305010057
Identification and Determination of Cannabinoids in both Commercially Available and Cannabis Oils Stored Long Term (full–2005) http://www.researchgate.net/publication/246498903_Identification_and_Determination_of_Cannabinoids_in_both_Commercially_Available_and_Cannabis_Oils_Stored_Long_Term
Pharmaceutical Formulation. US Patent 6946150 B27 (full–2005) http://www.cannabisinternational.org/info/nasal-spray.pdf
Pharmacokinetics of cannabinoids (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16237477
Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16596792
Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and Narachidonoyldopamine (NADA) in the rat isolated aorta (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15659311
Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15978942
Treatment of Tourette-syndrome with cannabinoids: results from clinical and neuroimaging studies (abst–2005) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2005-918789
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16191670
Cannabis may help keep arteries clear (news-2005) http://www.chanvre-info.ch/info/en/Cannabis-may-help-keep-arteries.html
Medical marijuana: study shows that THC slows atherosclerosis (news-2005) http://thenexthurrah.typepad.com/the_next_hurrah/2005/04/medical_marijua.html
Science: THC slows development of atherosclerosis in animal study (news-2005) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=190#1
Cannabis Spray for Bipolar (news-2005) http://www.prohealth.com/me-cfs/blog/boardDetail.cfm?id=565511
Chemicals in Cannabis may help mentally ill (news-2005) http://www.news-medical.net/news/2005/06/06/10716.aspx
THC effective in appetite and weight loss in severe lung disease (COPD) (news-2005)
http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=191#2
New Synthetic Delta-9-THC Inhaler Offers Safe, Rapid Delivery , Phase I Study (news-2005) http://www.medicalnewstoday.com/articles/22937.php
A pilot clinical study of Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360617/
top
A tale of two cannabinoids:The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (full-2006) http://mcforadhd.free.fr/Russo_Tale_of_Two_Cannabinoids_Med_Hypoth_2006.pdf
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-InCachexia-Study-Group (full-2006) http://jco.ascopubs.org/content/24/21/3394.long
A Molecular Link between the Active Component of Marijuana and Alzheimer’s Disease Pathology (full-2006) http://www.ukcia.org/research/AlzheimersDiseasePathology.pdf
{Delta}9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer Cells through Cdc2 Regulation (full-2006)
http://cancerres.aacrjournals.org/cgi/content/full/66/13/6615
Δ9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by
Translocation of Bad to Mitochondria (full-2006)
http://mcr.aacrjournals.org/content/4/8/549.full
Further Characterization of the Time-Dependent Vascular Effects of Δ9-Tetrahydrocannabinol (full-2006) http://jpet.aspetjournals.org/content/317/1/428.full
Cannabinoids and the Endocannabinoid System (full-2006)
http://www.cannabis-med.org/english/journal/en_2006_01_2.pdf
An Experimental Study of Catechol-O-Methyltransferase Val(158)Met Moderation of Delta-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition (full-2006) http://www.nature.com/npp/journal/v31/n12/full/1301197a.html
The Cannabinoid Cb1 Receptor Antagonist Rimonabant Attenuates the Hypotensive Effect of Smoked Marijuana in Male Smokers (full–2006) http://www.ahjonline.com/article/S0002-8703%2805%2901013-6/fulltext
US Patent Application 20060167084 – Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis (full-2006) http://www.google.it/patents/US20060167084
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia (full-forum repost-2006) http://www.420magazine.com/forums/anxiolytic-effects/149595-delta-9-tetrahydrocannabinol-nighttime-agitation-severe-dementia.html
Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16997463?dopt=Abstract
Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356) (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16953384
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare and pain relief (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16834825
top
Delta(9)-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity (abst-2006) http://www.unboundmedicine.com/medline/ebm/record/17140550/abstract/Delta_9__Tetrahydrocannabinol_protects_hippocampal_neurons_from_excitotoxicity
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16458258
The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury (abst-2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=166
Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16506408
Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16314952
THC and prochlorperazine effective in reducing vomiting in women following breast surgery (news-2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=219#1
Marijuana’s Active Ingredient Shown to Inhibit Primary Marker of Alzheimer’s Disease (news–2006) http://www.scripps.edu/newsandviews/e_20060828/news.html
THC inhibits primary marker of Alzheimer’s disease (news-2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=225#3
Cannabis destroys cancer cells (news-2006) http://www.news-medical.net/news/2006/03/01/16340.aspx
Cesamet, THC and chemotherapy (news–2006) http://www.sciencebase.com/science-blog/cesamet-thc.html
Cannabinoid Offers Cardioprotection (news-2006) http://norml.org/news/2006/02/16/cannabinoid-offers-cardioprotection-study-says
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/?tool=pubmed&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_SingleItemSupl.Pubmed_DiscoveryDbLinks&ordinalpos=1
Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771679/?tool=pubmed
The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport (full-2007) http://jpet.aspetjournals.org/content/321/1/370.full
top
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuana Smokers and Nonmarijuana Smokers (full-2007) http://www.nature.com/npp/journal/v32/n6/full/1301243a.html
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189766/?tool=pubmed
Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2083705/?tool=pubmed
CB2 receptors in the brain: role in central immune function (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez
Δ9-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189998/?tool=pmcentrez
Low dose combination of morphine and Δ9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040345/
The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells (full-2007) http://onlinelibrary.wiley.com/doi/10.1002/ijc.22917/pdf
On the pharmacological properties of Delta9-tetrahydrocannabinol (THC) (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17712813
Cerebellar-Dependent Learning as a Neurobehavioral Index of the Cannabinoid System (abst–2007) http://dl.begellhouse.com/journals/7b004699754c9fe6,64ecdd6045552415,684ce6ce63101f0f.html
The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor (abst-2007) http://www.unboundmedicine.com/medline/ebm/record/17588560/abstract/The_antinociceptive_effect_of_Delta9_tetrahydrocannabinol_in_the_arthritic_rat_involves_the_CB_2__cannabinoid_receptor
THC improves appetite and reverses weight loss in AIDS patients (abst-2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=189
Repeated Treatment with Cannabidiol but Not Delta9-tetrahydrocannabinol Has a Neuroprotective Effect Without the Development of Tolerance (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17320118
Synergy between Delta(9)-tetrahydrocannabinol and morphine in the arthritic rat (abst-2007) http://www.unboundmedicine.com/medline/ebm/record/17498686/abstract/Synergy_between_Delta_9__tetrahydrocannabinol_and_morphine_in_the_arthritic_rat
Delta(9)-tetrahydrocannabinol (Delta(9)-THC) prevents cerebral infarction via hypothalamic-independent hypothermia (abst-2007) http://www.unboundmedicine.com/medline/ebm/record/17289082/abstract/Delta_9__tetrahydrocannabinol__Delta_9__THC__prevents_cerebral_infarction_via_hypothalamic_independent_hypothermia
top
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17868014
Medicinal chemistry endeavors around the phytocannabinoids (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17712816
Effects of a Selective Cannabinoid Agonist and Antagonist on Body Temperature in Rats (abst-2007) http://www.fasebj.org/cgi/content/meeting_abstract/21/5/A409?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=800&resourcetype=HWCIT
Effects of different substance misuse in genital reflexes of paradoxical sleep deprived male rats (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17518911
Endocannabinoid system in cancer cachexia (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17563462
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17931597
Neural Substrates Underlying the Effects of Cannabinoids, and More (news–2007) http://www.alphagalileo.org/ViewItem.aspx?ItemId=11623&CultureCode=en
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
Δ9-Tetrahydrocannabinol Content of Commercially Available Hemp Products (full-2008) https://secure.manitobaharvest.com/images/uploads/pages/File/thc_study_jat_2008.pdf
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol (full-2008) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2279017
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells (full-2008) http://molpharm.aspetjournals.org/content/74/1/20.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block
Cannabinoids in the management of difficult to treat pain (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/?tool=pmcentrez
Cannabinoid receptors in acute and chronic complications of atherosclerosis (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/?tool=pmcentrez
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study (full-2008) http://www.scribd.com/doc/7718968/Antibacterial-Cannabinoids-From-Cannabis-Sativa-AStructureActivity-Study
The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677557/
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 (full-2008) http://jpet.aspetjournals.org/content/325/3/1007.long
top
Endocannabinoids in the retina: from marijuana to neuroprotection (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584875/
Evaluation of fatty acid amides in the carrageenan-induced paw edema model (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200792/
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? (full–2008) http://proxy.baremetal.com/cannabiscoalition.ca/info/Russo_Clinical_Endocannabin.pdf
Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/-mice (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751575/
US Patent 7399872 – Conversion of CBD to Δ-THC and Δ-THC (full-2008) https://www.google.com/patents/US7399872
Delta-9-tetrahydrocannabinol pharmacokinetics (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18847571
Cytotoxic and NF-κB-modulating effects of cannabis constituents (abst–2008) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0028-1084227
High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18615640
Effect of intrapulmonary tetrahydrocannabinol administration in humans (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18515447
Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/17675107
Anandamide effects on 5-HT(3) receptors in vivo (abst–2008) http://www.frontiersin.org/publications/18775693
Cannabinoids in the control of pain (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19388223
Science: THC reduces reflux of acid from the stomach (news–2008) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=285
Getting High For Your Health (news–2008) http://www.popsci.com/rachel-durfee/article/2008-09/getting-high-your-health
CSI: fingerprinting and drug detection in one (news–2008) http://arstechnica.com/science/2008/12/csi-fingerprinting-and-drug-detection-in-one/
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697695/?tool=pubmed
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum (full-2009) http://www.nature.com/npp/journal/v34/n3/full/npp2008138a.html
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells (full–2009) http://www.jbc.org/content/285/3/1616.full?sid=43211ca4-a4aa-4182-a554-d15e2835e288
Hydroxylation and Further Oxidation of Δ9-Tetrahydrocannabinol by Alkane-Degrading Bacteria (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786519/?tool=pmcentrez
top
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/?tool=pubmed
Cannabinoid Receptor 1 Binding Activity and Quantitative Analysis of Cannabis sativa L. Smoke and Vapor (full–2009) https://www.jstage.jst.go.jp/article/cpb/58/2/58_2_201/_pdf
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo (full–2009) http://www.pnas.org/content/106/48/20270.long
Opposite Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055598/pdf/npp2009184a.pdf
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
Evaluation of Prevalent Phytocannabinoids in the Acetic Acid Model of Visceral Nociception (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765124/?tool=pubmed
Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey (full-2009) http://www.hindawi.com/journals/arp/2009/827290.html
Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697772/?tool=pmcentrez
Actions of delta-9-tetrahydrocannabinol in cannabis (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731700/?tool=pmcentrez
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma (full-2009) http://mct.aacrjournals.org/content/8/7/1838.full
TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action (full–2009) http://www.landesbioscience.com/journals/autophagy/SalazarAUTO5-7.pdf
Cannabinoid action induces autophagymediated cell death through stimulation of ER
stress in human glioma cells (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673842/pdf/JCI37948.pdf
Pharmaceutical Compositions For The Treatment Of Chronic Obstructive Disease IS2009 / 0197941 A1 Aug. 6, 2009 (full–2009) http://www.cannabisinternational.org/info/COPD-Compositions.pdf
The analgesic potential of cannabinoids (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728280/
Modulation of effective connectivity during emotional processing by Delta9-tetrahydrocannabinol and cannabidiol (full-2009) http://ijnp.oxfordjournals.org/content/13/4/421.long
top
US Patent Application 20090197941 – Pharmaceutical Compositons for the Treatment of Chronic Obstructive Pulmonary Disease (full–2009) http://www.google.com/patents/US20090197941
Patent 7524881 – Production of Δ 9 tetrahydrocannabinol (full–2009) http://www.freepatentsonline.com/7524881.html
THC can improve symptoms of schizophrenia (article–2009) http://www.cannabis-med.org/data/pdf/en_2009_04_1_0.pdf
Role of the cannabinoids in glaucoma (article–2009) http://www.oftalmo.com/seo/archivos/maquetas/8/3E3FF941-D9FB-6F89-02E1-00007B09B2A8/articulo.pdf
Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19393686
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/18719045?ordinalpos=44&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19285266
Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19229996
Active cannabis chemicals halt prostate cancer cell growth (news-2009) http://www.news-medical.net/news/20090908/Active-cannabis-chemicals-halt-prostate-cancer-cellgrowth.aspx
Marijuana Chemicals Ease MS Symptoms, Review Confirms (news-2009)
http://www.drugfree.org/uncategorized/marijuana-chemicals-ease-ms
THC initiates brain cancer cells to destroy themselves (news-2009)
http://www.worldhealth.net/news/thc_initiates_brain_cancer_cells_to_dest/
Average Marijuana Potency by Year, 1975-2003 (news–2009) http://medicalmarijuana.procon.org/view.additional-resource.php?resourceID=191
Active Component Of Marijuana Has Anti-Cancer Effects, Study Suggests (news-2009) http://www.sciencedaily.com/releases/2009/04/090401181217.htm


THC ACID / THCA
The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L (full–2004) http://www.jbc.org/content/279/38/39767.long
Crystallization of Δ1-tetrahydrocannabinolic acid (THCA) synthase from Cannabis sativa (full-2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1952348&tool=pmcentrez
top
Unheated Cannabis sativa extracts and its major compound THC-acid have potential
immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways (full-2006) https://openaccess.leidenuniv.nl/bitstream/handle/1887/3744/07.pdf?sequence=6
THC inhibits primary marker of Alzheimer’s disease (news-2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=225#3
Identification and Characterization of Cannabinoids That Induce Cell Death through Mitochondrial Permeability Transition in Cannabis Leaf Cells (full–2007) http://www.jbc.org/content/282/28/20739.full?sid=a5db98db-ff96-4187-8790-57097bbe15c1
Production of THC acid by the biosynthetic enzyme secreted from transgenic Pichia pastoris (full-2007) http://www.sciencedirect.com/science/article/pii/S0006291X07015665
Cannabinoids act as necrosis-inducing factors in Cannabis sativa (full-2008) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2634471&tool=pmcentrez
US Patent 7399872 – Conversion of CBD to Δ-THC and Δ-THC (full-2008) https://www.google.com/patents/US7399872
Evaluation of Prevalent Phytocannabinoids in the Acetic Acid Model of Visceral Nociception (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765124/?tool=pubmed
Studies on tetrahydrocannabinolic acid synthase that produces the acidic precursor of tetrahydrocannabinol, the pharmacologically active cannabinoid in marijuana (full–2009) http://www.ddtjournal.com/action/downloaddoc.php?docid=218


THC-HS / TETRAHYDROCANNABINOL-HEMISUCCINATE
Chemical Stabilization of a Delta9-Tetrahydrocannabinol Prodrug in Polymeric Matrix
Systems Produced by a Hot-melt Method: Role of Microenvironment pH (full-2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750513/?tool=pubmed


TETRAHYDROCANNABIORCOL
Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15688956
top


THCV / TETRAHYDROCANNABIVARIN
Phytocannabinoids (news–undated) http://www.news-medical.net/health/Phytocannabinoids.aspx
Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study (full-2001) http://jat.oxfordjournals.org/content/25/7/565.long
Plant cannabinoids: a neglected pharmacological treasure trove (full-2005) http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1751232&tool=pmcentrez
Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751228/?tool=pubmed
Cannabis joins battle of the bulge (news–2005) http://tetrahydrocannabivarin.com/
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189766/?tool=pubmed
The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438968/
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full-2008)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
Weeding out the highs of medical marijuana (news–2008) http://www.alphagalileo.org/ViewItem.aspx?ItemId=4726&CultureCode=en
Non-psychotropic plant cannabinoids:new therapeutic opportunities from an
ancient herb (full-2009) http://www.onlinepot.org/medical/Izzo%20Plant%20Cannabinoids%20Therapeutic%20Opportunities%20TIPS%202009.pdf
Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697695/?tool=pubmed
top


Advertisements